Intended for healthcare professionals

  1. News & Views
  2. Covid-19: What do we...
  3. Covid-19: What do we know about “long covid”?
Feature

Covid-19: What do we know about “long covid”?

BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m2815 (Published 14 July 2020) Cite this as: BMJ 2020;370:m2815

Linked Opinion

A roller coaster of ill health, extreme emotions, and utter exhaustion

Linked Opinion

Prolonged and relapsing course of illness has implications for returning workers

Linked Opinion

Patients’ experiences of “longcovid” are missing from the NHS narrative

Related articles

BMJ opinionA roller coaster of ill health, extreme emotions, and utter exhaustion
BMJ opinionPatients’ experiences of “longcovid” are missing from the NHS narrative

See more

Cited by...

  • Neuro-COVID long-haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination
  • Variation in COVID-19 characteristics, treatment and outcomes in Michigan: an observational study in 32 hospitals
  • An untargeted metabolomic approach to identify antiviral defense mechanisms in memory leukocytes secreting in vitro IgG anti-SARS-Cov-2
  • The Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland (Study protocol)
  • Characterization of long-term patient-reported symptoms of COVID-19: an analysis of social media data
  • Avascular necrosis as a part of 'long COVID-19
  • Characterizing Long COVID: Deep Phenotype of a Complex Condition
  • Post-COVID symptoms reported at asynchronous virtual review and stratified follow-up after COVID-19 pneumonia
  • Long COVID symptoms from Reddit: Characterizing post-COVID syndrome from patient reports
  • Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series
  • Patient symptoms and experience following COVID-19: results from a UK wide survey
  • Characterising post-COVID syndrome more than 6 months after acute infection in adults; prospective longitudinal cohort study, England
  • Hair loss in females and thromboembolism in males are significantly enriched in post-acute sequelae of COVID (PASC) relative to recent medical history
  • Long COVID In Adults at 12 Months After Mild-to-Moderate SARS-CoV-2 Infection
  • Incidence of Long-term Post-acute Sequelae of SARS-CoV-2 Infection Related to Pain and Other Symptoms: A Living Systematic Review and Meta-analysis
  • SARS-CoV-2 binding to ACE2 triggers pericyte-mediated angiotensin-evoked cerebral capillary constriction
  • Acute and longer-term psychological distress associated with testing positive for COVID-19: longitudinal evidence from a population-based study of US adults
  • Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information
  • COVID-19: A need for new rather than repurposed antiviral drugs
  • Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis
  • The Risks and Benefits of Providing HIV Services during the COVID-19 Pandemic
  • Day by day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalised health-care workers: a 90-day follow-up study
  • Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia
  • Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis
  • Investigating mental and physical disorders associated with COVID-19 in online health forums
  • Estimating the burden of COVID-19 pandemic on mortality, life expectancy and lifespan inequality in England and Wales: A population-level analysis
  • The Kids Are Not Alright: A Preliminary Report of Post-COVID Syndrome in University Students
  • Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review
  • Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19
  • The covid-19 elimination debate needs correct data
  • Covid-19: Learn from other countries about easing lockdown, researchers urge
  • Should countries aim for elimination in the covid-19 pandemic?
  • Covid-19: prioritising rehabilitation when mortality figures dominate the headlines
  • "Long covid": the Dutch response
  • Covid-19: What we eat matters all the more now
Back to top